PHOENIX, Jan. 27, 2015 /PRNewswire/ -- Pennystocksinsiders.com (PSI) released FREE insider trading reports for US market investors to track the following active stocks and penny stocks: FXCM (NYSE:FXCM), Achillion Pharmaceuticals (NASDAQ:ACHN), Ariad Pharmaceuticals (NASDAQ:ARIA), Kinder Morgan (NYSE:KMI), Twitter (NYSE:TWTR), and Yahoo! (NASDAQ:YHOO).
(Read full report by clicking the link below, you may need to copy and paste the full link to your browser.)
FXCM Inc (NYSE:FXCM): By the end of last trading, the FXCM (NYSE:FXCM) shares earned US$0.07 (or 2.95%) to US$2.44 with about 32.42 million shares exchanged hands for the session, compared to its average volume of 15.62 million shares. The revenue growth came in higher than the industry average of 11.7%. From the same quarter one year prior, its revenues slightly increased by 2.4%. Growth in the company's revenue appears to have helped boost the earnings per share. The net income growth from the same quarter one year ago has significantly exceeded that of the S&P 500 and the Capital Markets industry. The net income increased by 146.7% when compared to the same quarter one year prior, rising from -US$5.12 million to US$2.39 million. Pennystocksinsiders.com found company 10% Owner, Michael Romersa, sold his shares at price of US$2.71 on January 22. Want to know when company insiders will buy or sell their shares? Want to monitor this company on an on-going basis?
Read Full Report: http://www.Pennystocksinsiders.com/PR/012715A/FXCM/FXCM.pdf
Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN): By the end of last trading session, the Achillion Pharmaceuticals (NASDAQ:ACHN) shares lost 2.47% (or US$0.39) to US$15.60 with about 6.42 million shares exchanged hands for the session, compared to its average volume of 7.37 million shares. The biopharmaceutical company has been on the move lately as the stock has risen by 22.4% in the past four weeks, and it is currently trading well above its 20-Day SMA. The Company is engaged in the development of antivirals for the treatment of chronic hepatitis C infection, and the development of antibacterials for the treatment of resistant bacterial infections. Pennystocksinsiders.com found company EVP and CFO, Mary Kay Fenton, sold her shares at price of US$16.00 on January 23. Want to track the company insiders in Achillion Pharmaceuticals are starting to buy or sell more company shares? See insider trade report for ACHN here.
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA): By the end of last trading session, the Ariad Pharmaceuticals (NASDAQ:ARIA) shares soared 4.43% (or US$0.27) to US$6.37 with about 3.76 million shares exchanged hands for the session, compared to its average volume of 5.73 million shares. Currently the debt-to-equity ratio of 1.91 is quite high overall and when compared to the industry average, suggesting that the current management of debt levels should be re-evaluated. Despite the company's weak debt-to-equity ratio, the company has managed to keep a very strong quick ratio of 3.85, which shows the ability to cover short-term cash needs. Pennystocksinsiders.com found company Chairman & CEO, Harvey J M D Berger, purchased her shares at price of US$6.16 ¨C US$6.18 on January 22 - 23. Want to track the company insiders in Ariad Pharmaceuticals are starting to buy or sell more company shares? See insider trade report for ARIA here.
Today Pennystocksinsiders.com also observed abnormal trade volume for the following companies; insiders may be involved in trading in these companies. It will take some time for insiders to report their trades. Read these reports and add these companies into your Insider Trade Radar.
Kinder Morgan Inc (NYSE:KMI):
Read Full Report: http://www.Pennystocksinsiders.com/PR/012715A/KMI/KinderMorgan.pdf
Twitter Inc (NYSE:TWTR):
Read Full Report: http://www.Pennystocksinsiders.com/PR/012715A/TWTR/Twitter.pdf
Yahoo! Inc. (NASDAQ:YHOO):
Read Full Report: http://www.Pennystocksinsiders.com/PR/012715A/YHOO/Yahoo.pdf
Insider Filing Source Reference: All observations, analyses and reports are based on public information released by the U.S. Securities and Exchange Commission.
Pennystocksinsiders.com features a team of experienced data analysts striving to provide the investment community with the tools, software, and data necessary to carry out more effective investment research.
Please visit Pennystocksinsiders.com/disclaimers/index.php for details.